Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ai |
RCV002224567 | SCV002502109 | uncertain significance | not provided | 2022-02-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003633604 | SCV004560983 | uncertain significance | Ehlers-Danlos syndrome, type 4 | 2023-09-10 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with COL3A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1677976). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs774425143, gnomAD 0.0009%). This sequence change falls in intron 20 of the COL3A1 gene. It does not directly change the encoded amino acid sequence of the COL3A1 protein. It affects a nucleotide within the consensus splice site. |